Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $75.3 million.

  • Prestige Consumer Healthcare's Free Cash Flow rose 1847.15% to $75.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $267.2 million, marking a year-over-year increase of 743.95%. This contributed to the annual value of $243.3 million for FY2025, which is 163.55% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Free Cash Flow stood at $75.3 million for Q4 2025, which was up 1847.15% from $55.4 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Free Cash Flow's 5-year high stood at $78.2 million during Q2 2025, with a 5-year trough of $46.6 million in Q2 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's median Free Cash Flow value was $59.0 million (recorded in 2021), while the average stood at $60.9 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Free Cash Flow surged by 4728.61% in 2021 and then plummeted by 1851.4% in 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's Free Cash Flow (Quarter) stood at $64.1 million in 2021, then dropped by 17.06% to $53.1 million in 2022, then surged by 30.74% to $69.5 million in 2023, then fell by 8.57% to $63.5 million in 2024, then grew by 18.47% to $75.3 million in 2025.
  • Its Free Cash Flow was $75.3 million in Q4 2025, compared to $55.4 million in Q3 2025 and $78.2 million in Q2 2025.